Earnings History Data for Aptose Biosciences, Inc. (APTO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aptose Biosciences, Inc.
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | AH | APTO | Aptose Biosciences, Inc. | 11.84 | -1.44 | -1.48 | -1.65 | Aptose Biosciences GAAP EPS of -$7.58 beats by $0.40 [3/26/2024 4:50 PM] |
1.51 | -0.09 (-5.62%) |
1.50 | -0.10 (-6.25%) |
1.36 - 10.12 | 65,353 | 70,000 | 11,650 | ||
| 09-11-2023 | AH | APTO | Aptose Biosciences, Inc. | 19.95 | -1.76 | -2.16 | -1.65 | Aptose Biosciences GAAP EPS of -$1.76 beats by $0.22 [11/9/2023 4:51 PM] |
2.43 | -0.81 (-25.00%) |
3.17 | -0.07 (-2.16%) |
2.14 - 11.55 | 43,068 | 50,000 | 1,732 | ||
| 10-08-2023 | AH | APTO | Aptose Biosciences, Inc. | 23.25 | -2.27 | -2.09 | -1.65 | Aptose Biosciences GAAP EPS of -$2.27 misses by $0.34 [8/10/2023 4:58 PM] |
4.24 | 0.24 (6.00%) |
4.04 | 0.04 (1.00%) |
2.91 - 13.20 | 38,594 | 50,000 | 286 | ||
| 08-05-2023 | AH | 4:00 PM ET (May 8) |
APTO | Aptose Biosciences, Inc. | 48.56 | -0.15 | -0.12 | -0.12 | Aptose Biosciences GAAP EPS of -$0.15 misses by $0.03 [5/9/2023 10:27 AM] |
0.51 | -0.02 (-3.77%) |
0.50 | -0.03 (-5.66%) |
0.43 - 1.18 | 323,090 | 210,000 | 3,030 | |
| 23-03-2023 | AH | 4:00 PM ET (Mar 23) |
APTO | Aptose Biosciences, Inc. | 58.62 | -0.11 | -0.11 | -0.27 | Aptose Biosciences GAAP EPS of -$0.45 beats by $0.01 [3/23/2023 4:48 PM] |
0.6540 | 0.08 (14.72%) |
0.57 | 0.0 (-0.02%) |
0.43 - 1.55 | 429,448 | 140,000 | 2,337 | |
| 01-11-2022 | AH | 4:00 PM ET (Nov 1) |
APTO | Aptose Biosciences, Inc. | 44.77 | -0.11 | -0.12 | -0.13 | Aptose Biosciences GAAP EPS of -$0.11 beats by $0.01 [11/1/2022 4:40 PM] |
0.55 | 0.05 (10.26%) |
0.50 | 0.0 (0.24%) |
0.45 - 2.78 | 1,922,119 | 570,000 | 14,524 | |
| 02-08-2022 | AH | 4:00 PM ET (Aug 2) |
APTO | Aptose Biosciences, Inc. | 71.02 | -0.11 | -0.13 | -0.15 | Aptose Biosciences GAAP EPS of -$0.11 beats by $0.02 [8/2/2022 4:04 PM] |
0.7758 | 0.06 (8.96%) |
0.80 | 0.09 (12.35%) |
0.71 - 3.12 | 351,919 | 140,000 | 32,945 | |
| 09-05-2022 | AH | 4:00 PM ET (May 9) |
APTO | Aptose Biosciences, Inc. | 112.52 | -0.12 | -0.15 | -0.18 | Aptose Biosciences GAAP EPS of -$0.12 beats by $0.02 [5/9/2022 4:33 PM] |
1.07 | -0.04 (-4.02%) |
1.09 | -0.03 (-2.68%) |
1.00 - 5.78 | 742,253 | 530,000 | 253 | |
| 22-03-2022 | AH | 4:00 PM ET (Mar 22) |
APTO | Aptose Biosciences, Inc. | 108.52 | -0.27 | -0.18 | -0.17 | Aptose Biosciences GAAP EPS of -$0.27 misses by $0.11 [3/22/2022 4:15 PM] |
1.23 | -0.05 (-4.30%) |
1.14 | -0.14 (-10.94%) |
1.00 - 7.20 | 531,225 | 380,000 | 15,657 | |
| 11-11-2021 | AH | 4:00 PM ET (Nov 11) |
APTO | Aptose Biosciences, Inc. | 217.03 | -0.13 | -0.17 | -0.15 | Aptose Biosciences EPS beats by $0.04 [11/11/2021 4:37 PM] |
2.65 | 0.25 (10.42%) |
2.56 | 0.16 (6.67%) |
2.02 - 7.27 | 1,941,901 | 910,000 | 65,162 | |
| 03-08-2021 | AH | 4:00 PM ET (Aug 3) |
APTO | Aptose Biosciences, Inc. | 235.33 | -0.15 | -0.18 | -0.21 | Aptose Biosciences EPS beats by $0.04 [8/3/2021 4:04 PM] |
2.61 | -0.02 (-0.95%) |
2.66 | 0.03 (1.14%) |
2.55 - 7.27 | 767,135 | 1,030,000 | 9,822 | |
| 04-05-2021 | AH | 4:00 PM ET (May 4) |
APTO | Aptose Biosciences, Inc. | 492.53 | -0.18 | -0.17 | -0.15 | Aptose Biosciences EPS misses by $0.01 [5/4/2021 4:02 PM] |
4.91 | -0.58 (-10.56%) |
5.35 | -0.14 (-2.55%) |
3.39 - 9.00 | 2,144,344 | 780,000 | 17,692 | |
| 23-03-2021 | AH | 4:00 PM ET (Mar 23) |
APTO | Aptose Biosciences, Inc. | 341.19 | -0.17 | -0.16 | -0.13 | Aptose Biosciences EPS in-line [3/23/2021 4:04 PM] |
5.95 | 2.28 (62.13%) |
5.35 | 1.68 (45.78%) |
3.39 - 9.00 | 173,104,404 | 1,050,000 | 5,921,639 | |
|
||||||||||||||||||
| 10-11-2020 | AH | 4:00 PM ET (Nov 10) |
APTO | Aptose Biosciences, Inc. | 414.67 | -0.15 | -0.18 | -0.12 | Aptose Biosciences EPS beats by $0.04 [11/10/2020 4:03 PM] |
5.21 | 0.68 (15.01%) |
4.59 | 0.06 (1.32%) |
2.32 - 9.25 | 1,831,945 | 762,618 | 14,231 | |
|
|
||||||||||||||||||
| 04-08-2020 | AH | 4:00 PM ET (Aug 4) |
APTO | Aptose Biosciences, Inc. | 439.08 | -0.21 | -0.15 | -0.13 | Aptose Biosciences EPS misses by $0.05 [8/4/2020 4:12 PM] |
5.48 | 0.34 (6.61%) |
5.15 | 0.01 (0.19%) |
1.82 - 9.25 | 1,106,502 | 1,075,477 | 24,385 | |
|
|
||||||||||||||||||
| 05-05-2020 | AH | 4:00 PM ET (May 5) |
APTO | Aptose Biosciences, Inc. | 519.42 | -0.15 | -0.10 | -0.14 | Aptose Biosciences EPS misses by $0.05 [5/5/2020 4:07 PM] |
7.11 | 0.29 (4.25%) |
6.95 | -0.16 (-2.25%) |
1.81 - 9.25 | 762,436 | 1,086,025 | 850 | |
|
|
||||||||||||||||||